1 Market Overview

1.1 Product Overview and Scope of Retinal Disorders Therapy

1.2 Classification of Retinal Disorders Therapy by Type

1.2.1 Overview: Global Retinal Disorders Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Retinal Disorders Therapy Revenue Market Share by Type in 2021

1.2.3 Age Related Macular Degeneration

1.2.4 Diabetic Retinopathy

1.2.5 Ocular Inflammatory Disease (Uveitis)

1.2.6 Macular Hole

1.3 Global Retinal Disorders Therapy Market by Application

1.3.1 Overview: Global Retinal Disorders Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Retinal Disorders Therapy Market Size & Forecast

1.5 Global Retinal Disorders Therapy Market Size and Forecast by Region

1.5.1 Global Retinal Disorders Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Retinal Disorders Therapy Market Size by Region, (2017-2022)

1.5.3 North America Retinal Disorders Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Retinal Disorders Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Retinal Disorders Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Retinal Disorders Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Retinal Disorders Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Retinal Disorders Therapy Market Drivers

1.6.2 Retinal Disorders Therapy Market Restraints

1.6.3 Retinal Disorders Therapy Trends Analysis

2 Company Profiles

2.1 ALLERGAN

2.1.1 ALLERGAN Details

2.1.2 ALLERGAN Major Business

2.1.3 ALLERGAN Retinal Disorders Therapy Product and Solutions

2.1.4 ALLERGAN Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 ALLERGAN Recent Developments and Future Plans

2.2 AbbVie

2.2.1 AbbVie Details

2.2.2 AbbVie Major Business

2.2.3 AbbVie Retinal Disorders Therapy Product and Solutions

2.2.4 AbbVie Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 AbbVie Recent Developments and Future Plans

2.3 Alimera Sciences

2.3.1 Alimera Sciences Details

2.3.2 Alimera Sciences Major Business

2.3.3 Alimera Sciences Retinal Disorders Therapy Product and Solutions

2.3.4 Alimera Sciences Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Alimera Sciences Recent Developments and Future Plans

2.4 Janssen Biotech

2.4.1 Janssen Biotech Details

2.4.2 Janssen Biotech Major Business

2.4.3 Janssen Biotech Retinal Disorders Therapy Product and Solutions

2.4.4 Janssen Biotech Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Janssen Biotech Recent Developments and Future Plans

2.5 Swedish Orphan Biovitrum

2.5.1 Swedish Orphan Biovitrum Details

2.5.2 Swedish Orphan Biovitrum Major Business

2.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Product and Solutions

2.5.4 Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Swedish Orphan Biovitrum Recent Developments and Future Plans

2.6 Roche

2.6.1 Roche Details

2.6.2 Roche Major Business

2.6.3 Roche Retinal Disorders Therapy Product and Solutions

2.6.4 Roche Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Roche Recent Developments and Future Plans

2.7 Bristol-Myers Squibb

2.7.1 Bristol-Myers Squibb Details

2.7.2 Bristol-Myers Squibb Major Business

2.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Product and Solutions

2.7.4 Bristol-Myers Squibb Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.8 Genzyme

2.8.1 Genzyme Details

2.8.2 Genzyme Major Business

2.8.3 Genzyme Retinal Disorders Therapy Product and Solutions

2.8.4 Genzyme Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Genzyme Recent Developments and Future Plans

2.9 Genentech

2.9.1 Genentech Details

2.9.2 Genentech Major Business

2.9.3 Genentech Retinal Disorders Therapy Product and Solutions

2.9.4 Genentech Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Genentech Recent Developments and Future Plans

2.10 OCULAR THERAPEUTIX

2.10.1 OCULAR THERAPEUTIX Details

2.10.2 OCULAR THERAPEUTIX Major Business

2.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Product and Solutions

2.10.4 OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 OCULAR THERAPEUTIX Recent Developments and Future Plans

2.11 Bausch & Lomb

2.11.1 Bausch & Lomb Details

2.11.2 Bausch & Lomb Major Business

2.11.3 Bausch & Lomb Retinal Disorders Therapy Product and Solutions

2.11.4 Bausch & Lomb Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bausch & Lomb Recent Developments and Future Plans

2.12 UCBCares

2.12.1 UCBCares Details

2.12.2 UCBCares Major Business

2.12.3 UCBCares Retinal Disorders Therapy Product and Solutions

2.12.4 UCBCares Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 UCBCares Recent Developments and Future Plans

2.13 Aier Eye Hospital

2.13.1 Aier Eye Hospital Details

2.13.2 Aier Eye Hospital Major Business

2.13.3 Aier Eye Hospital Retinal Disorders Therapy Product and Solutions

2.13.4 Aier Eye Hospital Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Aier Eye Hospital Recent Developments and Future Plans

2.14 Alcon Holdings, Inc.

2.14.1 Alcon Holdings, Inc. Details

2.14.2 Alcon Holdings, Inc. Major Business

2.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Product and Solutions

2.14.4 Alcon Holdings, Inc. Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Alcon Holdings, Inc. Recent Developments and Future Plans

2.15 Eyebright Medical

2.15.1 Eyebright Medical Details

2.15.2 Eyebright Medical Major Business

2.15.3 Eyebright Medical Retinal Disorders Therapy Product and Solutions

2.15.4 Eyebright Medical Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Eyebright Medical Recent Developments and Future Plans

2.16 Kanghong Pharmaceutical

2.16.1 Kanghong Pharmaceutical Details

2.16.2 Kanghong Pharmaceutical Major Business

2.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Product and Solutions

2.16.4 Kanghong Pharmaceutical Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Kanghong Pharmaceutical Recent Developments and Future Plans

2.17 Huaxia Eye Hospital

2.17.1 Huaxia Eye Hospital Details

2.17.2 Huaxia Eye Hospital Major Business

2.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Product and Solutions

2.17.4 Huaxia Eye Hospital Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Huaxia Eye Hospital Recent Developments and Future Plans

2.18 Xingqi Pharmaceutical

2.18.1 Xingqi Pharmaceutical Details

2.18.2 Xingqi Pharmaceutical Major Business

2.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Product and Solutions

2.18.4 Xingqi Pharmaceutical Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Xingqi Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Retinal Disorders Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Retinal Disorders Therapy Players Market Share in 2021

3.2.2 Top 10 Retinal Disorders Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Retinal Disorders Therapy Players Head Office, Products and Services Provided

3.4 Retinal Disorders Therapy Mergers & Acquisitions

3.5 Retinal Disorders Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Retinal Disorders Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Retinal Disorders Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Retinal Disorders Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Retinal Disorders Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Retinal Disorders Therapy Revenue by Type (2017-2028)

6.2 North America Retinal Disorders Therapy Revenue by Application (2017-2028)

6.3 North America Retinal Disorders Therapy Market Size by Country

6.3.1 North America Retinal Disorders Therapy Revenue by Country (2017-2028)

6.3.2 United States Retinal Disorders Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Retinal Disorders Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Retinal Disorders Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Retinal Disorders Therapy Revenue by Type (2017-2028)

7.2 Europe Retinal Disorders Therapy Revenue by Application (2017-2028)

7.3 Europe Retinal Disorders Therapy Market Size by Country

7.3.1 Europe Retinal Disorders Therapy Revenue by Country (2017-2028)

7.3.2 Germany Retinal Disorders Therapy Market Size and Forecast (2017-2028)

7.3.3 France Retinal Disorders Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Retinal Disorders Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Retinal Disorders Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Retinal Disorders Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Retinal Disorders Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Region

8.3.1 Asia-Pacific Retinal Disorders Therapy Revenue by Region (2017-2028)

8.3.2 China Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8.3.5 India Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Retinal Disorders Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Retinal Disorders Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Retinal Disorders Therapy Revenue by Type (2017-2028)

9.2 South America Retinal Disorders Therapy Revenue by Application (2017-2028)

9.3 South America Retinal Disorders Therapy Market Size by Country

9.3.1 South America Retinal Disorders Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Retinal Disorders Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Retinal Disorders Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Retinal Disorders Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Retinal Disorders Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Country

10.3.1 Middle East & Africa Retinal Disorders Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Retinal Disorders Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Retinal Disorders Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Retinal Disorders Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Retinal Disorders Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Retinal Disorders Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Retinal Disorders Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Retinal Disorders Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Retinal Disorders Therapy Revenue Market Share by Region (2023-2028)

Table 6. ALLERGAN Corporate Information, Head Office, and Major Competitors

Table 7. ALLERGAN Major Business

Table 8. ALLERGAN Retinal Disorders Therapy Product and Solutions

Table 9. ALLERGAN Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. AbbVie Corporate Information, Head Office, and Major Competitors

Table 11. AbbVie Major Business

Table 12. AbbVie Retinal Disorders Therapy Product and Solutions

Table 13. AbbVie Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Alimera Sciences Corporate Information, Head Office, and Major Competitors

Table 15. Alimera Sciences Major Business

Table 16. Alimera Sciences Retinal Disorders Therapy Product and Solutions

Table 17. Alimera Sciences Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Janssen Biotech Corporate Information, Head Office, and Major Competitors

Table 19. Janssen Biotech Major Business

Table 20. Janssen Biotech Retinal Disorders Therapy Product and Solutions

Table 21. Janssen Biotech Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Swedish Orphan Biovitrum Corporate Information, Head Office, and Major Competitors

Table 23. Swedish Orphan Biovitrum Major Business

Table 24. Swedish Orphan Biovitrum Retinal Disorders Therapy Product and Solutions

Table 25. Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Roche Corporate Information, Head Office, and Major Competitors

Table 27. Roche Major Business

Table 28. Roche Retinal Disorders Therapy Product and Solutions

Table 29. Roche Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 31. Bristol-Myers Squibb Major Business

Table 32. Bristol-Myers Squibb Retinal Disorders Therapy Product and Solutions

Table 33. Bristol-Myers Squibb Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Genzyme Corporate Information, Head Office, and Major Competitors

Table 35. Genzyme Major Business

Table 36. Genzyme Retinal Disorders Therapy Product and Solutions

Table 37. Genzyme Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Genentech Corporate Information, Head Office, and Major Competitors

Table 39. Genentech Major Business

Table 40. Genentech Retinal Disorders Therapy Product and Solutions

Table 41. Genentech Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. OCULAR THERAPEUTIX Corporate Information, Head Office, and Major Competitors

Table 43. OCULAR THERAPEUTIX Major Business

Table 44. OCULAR THERAPEUTIX Retinal Disorders Therapy Product and Solutions

Table 45. OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bausch & Lomb Corporate Information, Head Office, and Major Competitors

Table 47. Bausch & Lomb Major Business

Table 48. Bausch & Lomb Retinal Disorders Therapy Product and Solutions

Table 49. Bausch & Lomb Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. UCBCares Corporate Information, Head Office, and Major Competitors

Table 51. UCBCares Major Business

Table 52. UCBCares Retinal Disorders Therapy Product and Solutions

Table 53. UCBCares Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Aier Eye Hospital Corporate Information, Head Office, and Major Competitors

Table 55. Aier Eye Hospital Major Business

Table 56. Aier Eye Hospital Retinal Disorders Therapy Product and Solutions

Table 57. Aier Eye Hospital Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Alcon Holdings, Inc. Corporate Information, Head Office, and Major Competitors

Table 59. Alcon Holdings, Inc. Major Business

Table 60. Alcon Holdings, Inc. Retinal Disorders Therapy Product and Solutions

Table 61. Alcon Holdings, Inc. Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Eyebright Medical Corporate Information, Head Office, and Major Competitors

Table 63. Eyebright Medical Major Business

Table 64. Eyebright Medical Retinal Disorders Therapy Product and Solutions

Table 65. Eyebright Medical Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Kanghong Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 67. Kanghong Pharmaceutical Major Business

Table 68. Kanghong Pharmaceutical Retinal Disorders Therapy Product and Solutions

Table 69. Kanghong Pharmaceutical Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Huaxia Eye Hospital Corporate Information, Head Office, and Major Competitors

Table 71. Huaxia Eye Hospital Major Business

Table 72. Huaxia Eye Hospital Retinal Disorders Therapy Product and Solutions

Table 73. Huaxia Eye Hospital Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Xingqi Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 75. Xingqi Pharmaceutical Major Business

Table 76. Xingqi Pharmaceutical Retinal Disorders Therapy Product and Solutions

Table 77. Xingqi Pharmaceutical Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Global Retinal Disorders Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 79. Global Retinal Disorders Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 80. Breakdown of Retinal Disorders Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Retinal Disorders Therapy Players Head Office, Products and Services Provided

Table 82. Retinal Disorders Therapy Mergers & Acquisitions in the Past Five Years

Table 83. Retinal Disorders Therapy New Entrants and Expansion Plans

Table 84. Global Retinal Disorders Therapy Revenue (USD Million) by Type (2017-2022)

Table 85. Global Retinal Disorders Therapy Revenue Share by Type (2017-2022)

Table 86. Global Retinal Disorders Therapy Revenue Forecast by Type (2023-2028)

Table 87. Global Retinal Disorders Therapy Revenue by Application (2017-2022)

Table 88. Global Retinal Disorders Therapy Revenue Forecast by Application (2023-2028)

Table 89. North America Retinal Disorders Therapy Revenue by Type (2017-2022) & (USD Million)

Table 90. North America Retinal Disorders Therapy Revenue by Type (2023-2028) & (USD Million)

Table 91. North America Retinal Disorders Therapy Revenue by Application (2017-2022) & (USD Million)

Table 92. North America Retinal Disorders Therapy Revenue by Application (2023-2028) & (USD Million)

Table 93. North America Retinal Disorders Therapy Revenue by Country (2017-2022) & (USD Million)

Table 94. North America Retinal Disorders Therapy Revenue by Country (2023-2028) & (USD Million)

Table 95. Europe Retinal Disorders Therapy Revenue by Type (2017-2022) & (USD Million)

Table 96. Europe Retinal Disorders Therapy Revenue by Type (2023-2028) & (USD Million)

Table 97. Europe Retinal Disorders Therapy Revenue by Application (2017-2022) & (USD Million)

Table 98. Europe Retinal Disorders Therapy Revenue by Application (2023-2028) & (USD Million)

Table 99. Europe Retinal Disorders Therapy Revenue by Country (2017-2022) & (USD Million)

Table 100. Europe Retinal Disorders Therapy Revenue by Country (2023-2028) & (USD Million)

Table 101. Asia-Pacific Retinal Disorders Therapy Revenue by Type (2017-2022) & (USD Million)

Table 102. Asia-Pacific Retinal Disorders Therapy Revenue by Type (2023-2028) & (USD Million)

Table 103. Asia-Pacific Retinal Disorders Therapy Revenue by Application (2017-2022) & (USD Million)

Table 104. Asia-Pacific Retinal Disorders Therapy Revenue by Application (2023-2028) & (USD Million)

Table 105. Asia-Pacific Retinal Disorders Therapy Revenue by Region (2017-2022) & (USD Million)

Table 106. Asia-Pacific Retinal Disorders Therapy Revenue by Region (2023-2028) & (USD Million)

Table 107. South America Retinal Disorders Therapy Revenue by Type (2017-2022) & (USD Million)

Table 108. South America Retinal Disorders Therapy Revenue by Type (2023-2028) & (USD Million)

Table 109. South America Retinal Disorders Therapy Revenue by Application (2017-2022) & (USD Million)

Table 110. South America Retinal Disorders Therapy Revenue by Application (2023-2028) & (USD Million)

Table 111. South America Retinal Disorders Therapy Revenue by Country (2017-2022) & (USD Million)

Table 112. South America Retinal Disorders Therapy Revenue by Country (2023-2028) & (USD Million)

Table 113. Middle East & Africa Retinal Disorders Therapy Revenue by Type (2017-2022) & (USD Million)

Table 114. Middle East & Africa Retinal Disorders Therapy Revenue by Type (2023-2028) & (USD Million)

Table 115. Middle East & Africa Retinal Disorders Therapy Revenue by Application (2017-2022) & (USD Million)

Table 116. Middle East & Africa Retinal Disorders Therapy Revenue by Application (2023-2028) & (USD Million)

Table 117. Middle East & Africa Retinal Disorders Therapy Revenue by Country (2017-2022) & (USD Million)

Table 118. Middle East & Africa Retinal Disorders Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Retinal Disorders Therapy Picture

Figure 2. Global Retinal Disorders Therapy Revenue Market Share by Type in 2021

Figure 3. Age Related Macular Degeneration

Figure 4. Diabetic Retinopathy

Figure 5. Ocular Inflammatory Disease (Uveitis)

Figure 6. Macular Hole

Figure 7. Retinal Disorders Therapy Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Others Picture

Figure 11. Global Retinal Disorders Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Retinal Disorders Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Retinal Disorders Therapy Revenue Market Share by Region (2017-2028)

Figure 14. Global Retinal Disorders Therapy Revenue Market Share by Region in 2021

Figure 15. North America Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Retinal Disorders Therapy Market Drivers

Figure 21. Retinal Disorders Therapy Market Restraints

Figure 22. Retinal Disorders Therapy Market Trends

Figure 23. ALLERGAN Recent Developments and Future Plans

Figure 24. AbbVie Recent Developments and Future Plans

Figure 25. Alimera Sciences Recent Developments and Future Plans

Figure 26. Janssen Biotech Recent Developments and Future Plans

Figure 27. Swedish Orphan Biovitrum Recent Developments and Future Plans

Figure 28. Roche Recent Developments and Future Plans

Figure 29. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 30. Genzyme Recent Developments and Future Plans

Figure 31. Genentech Recent Developments and Future Plans

Figure 32. OCULAR THERAPEUTIX Recent Developments and Future Plans

Figure 33. Bausch & Lomb Recent Developments and Future Plans

Figure 34. UCBCares Recent Developments and Future Plans

Figure 35. Aier Eye Hospital Recent Developments and Future Plans

Figure 36. Alcon Holdings, Inc. Recent Developments and Future Plans

Figure 37. Eyebright Medical Recent Developments and Future Plans

Figure 38. Kanghong Pharmaceutical Recent Developments and Future Plans

Figure 39. Huaxia Eye Hospital Recent Developments and Future Plans

Figure 40. Xingqi Pharmaceutical Recent Developments and Future Plans

Figure 41. Global Retinal Disorders Therapy Revenue Share by Players in 2021

Figure 42. Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Retinal Disorders Therapy Revenue Market Share in 2021

Figure 44. Global Top 10 Players Retinal Disorders Therapy Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Retinal Disorders Therapy Revenue Share by Type in 2021

Figure 47. Global Retinal Disorders Therapy Market Share Forecast by Type (2023-2028)

Figure 48. Global Retinal Disorders Therapy Revenue Share by Application in 2021

Figure 49. Global Retinal Disorders Therapy Market Share Forecast by Application (2023-2028)

Figure 50. North America Retinal Disorders Therapy Sales Market Share by Type (2017-2028)

Figure 51. North America Retinal Disorders Therapy Sales Market Share by Application (2017-2028)

Figure 52. North America Retinal Disorders Therapy Revenue Market Share by Country (2017-2028)

Figure 53. United States Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Retinal Disorders Therapy Sales Market Share by Type (2017-2028)

Figure 57. Europe Retinal Disorders Therapy Sales Market Share by Application (2017-2028)

Figure 58. Europe Retinal Disorders Therapy Revenue Market Share by Country (2017-2028)

Figure 59. Germany Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Retinal Disorders Therapy Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Retinal Disorders Therapy Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Retinal Disorders Therapy Revenue Market Share by Region (2017-2028)

Figure 67. China Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Retinal Disorders Therapy Sales Market Share by Type (2017-2028)

Figure 74. South America Retinal Disorders Therapy Sales Market Share by Application (2017-2028)

Figure 75. South America Retinal Disorders Therapy Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Retinal Disorders Therapy Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Retinal Disorders Therapy Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Retinal Disorders Therapy Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Retinal Disorders Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source